News & Updates

Continuous glucose monitoring (CGM) is transforming diabetes care in both type 1 diabetes (T1D) and type 2 diabetes (T2D), with or without insulin use, said Dr Pratik Choudhary, Honorary Consultant and Professor at the University of Leicester, UK, during an Abbott-sponsored symposium at ATTD-Asia 2025 in Singapore.

The combination of adjuvant abemaciclib and endocrine therapy (ET) significantly improves overall survival in patients with HR-positive, HER2-negative, node-positive, high-risk early breast cancer compared with ET alone, the phase III monarchE trial has shown.

The use of paracetamol during pregnancy does not appear to increase the likelihood of autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), or intellectual disability in children, according to the results of a systematic review and meta-analysis.